TABLE 1.
Patient demographics and characteristics of individuals admitted with an inflammatory bowel disease (IBD) exacerbation and IBD primary discharge diagnosis
| Characteristic | Age, years | P | |
|---|---|---|---|
|
| |||
| >65 (n=62) | 19–50 (n=76) | ||
| Male sex, % | 37 | 45 | 0.39 |
| Age, years, median (IQR) | 73 (69–78) | 31 (25–41) | |
| Crohn disease subjects, % | 63 | 64 | 0.86 |
| Duration of IBD before admission, years, median | 6 | 7 | 0.17 |
| IQR | 1–29 | 0–14 | |
| Range | 0–59 | 0–30 | |
| Hospital stay, nights, median (IQR) | 6.5 (3–11) | 6 (4–9) | 0.58 |
| Symptoms at presentation, % | |||
| Abdominal pain | 69 | 74 | 0.70 |
| Decreased oral intake | 45 | 26 | 0.03 |
| Diarrhea | 68 | 66 | 0.86 |
| Failure to thrive | 27 | 28 | 1 |
| Rectal bleeding | 39 | 47 | 0.39 |
| Vomiting | 31 | 29 | 0.85 |
| Family history of IBD, % | 15 | 25 | 0.14 |
| Extraintestinal manifestations, % | |||
| Arthritis | 0 | 8 | 0.033 |
| Iritis or uveitis | 0 | 3 | 0.50 |
| Sclerosing cholangitis | 0 | 3 | 0.50 |
| IBD complications, % | |||
| Abdominal infections | 2 | 0 | 0.45 |
| Infections due to immunosuppressant medications | 2 | 0 | 0.45 |
| Fractures | 0 | 0 | |
| Venous thrombosis | 5 | 1 | 0.33 |
| Charlson comorbidity index score, % | |||
| 0 | 73 | 96 | <0.001 |
| 1 | 11 | 3 | |
| 2 | 5 | 0.0 | |
| ≥3 | 11 | 1 | |
| Discharge disposition, % | |||
| Home | 98.4 | 98.7 | 1 |
| Nursing home | 1.6 | 0 | |
| Other hospital | 0 | 1.3 | |
| Death | 0 | 0 | |
IQR Interquartile range